Questions on AstraZeneca’s COVID-19 vaccine continue to linger despite reassurances

As of 31 March, the EMA identified 62 cases of CVST in the world, among 9.2 million doses of AstraZeneca administered.

from http://www.firstpost.com/world/questions-on-astrazenecas-covid-19-vaccine-continue-to-linger-despite-reassurances-9496621.html